Sequential Therapy in Metastatic Renal Cell Carinoma

NCT01731158 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma

Interventions

DRUG: Avastin in combination with Roferon-A
DRUG: Afinitor
DRUG: TKI: Sutent, Nexavar or Votrient

Sponsor

Central European Society for Anticancer Drug Research